Cargando…

Perinatal Depression and Anxiety in Women With Multiple Sclerosis: A Population-Based Cohort Study

OBJECTIVE: To assess the occurrence of perinatal depression and anxiety in women before and after diagnosis of multiple sclerosis (MS). METHODS: A total of 114,629 pregnant women were included in the Norwegian Mother, Father and Child Cohort study (1999–2008). We assessed depression and anxiety by q...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eid, Karine, Torkildsen, Øivind Fredvik, Aarseth, Jan, Flemmen, Heidi Øyen, Holmøy, Trygve, Lorentzen, Åslaug Rudjord, Myhr, Kjell-Morten, Riise, Trond, Simonsen, Cecilia, Torkildsen, Cecilie Fredvik, Wergeland, Stig, Willumsen, Johannes Sverre, Øksendal, Nina, Gilhus, Nils Erik, Bjørk, Marte-Helene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205461/ https://www.ncbi.nlm.nih.gov/pubmed/33883236 http://dx.doi.org/10.1212/WNL.0000000000012062

Ejemplares similares

Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy
por: Eid, Karine, et al.
Publicado: (2022)

Association of adverse childhood experiences with the development of multiple sclerosis
por: Eid, Karine, et al.
Publicado: (2022)

Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS
por: Torkildsen, Øivind, et al.
Publicado: (2014)

Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments
por: Torkildsen, Øivind, et al.
Publicado: (2014)

Month of birth and risk of multiple sclerosis: confounding and adjustments
por: Torkildsen, Øivind, et al.
Publicado: (2014)

Safety and efficacy of rituximab as first- and second line treatment in multiple sclerosis – A cohort study
por: Torgauten, Hilde Marie, et al.
Publicado: (2021)

Dietary Vitamin D3 Supplements Reduce Demyelination in the Cuprizone Model
por: Wergeland, Stig, et al.
Publicado: (2011)

Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder
por: Holmøy, Trygve, et al.
Publicado: (2020)

Safety of breast feeding during rituximab treatment in multiple sclerosis
por: Rød, Brit Ellen, et al.
Publicado: (2023)

Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis
por: Røsjø, Egil, et al.
Publicado: (2020)

Deep Gray Matter Demyelination Detected by Magnetization Transfer Ratio in the Cuprizone Model
por: Fjær, Sveinung, et al.
Publicado: (2013)

Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations
por: König, Marton, et al.
Publicado: (2023)

Extensive Multiple Sclerosis Reactivation after Switching from Fingolimod to Rituximab
por: Holmøy, Trygve, et al.
Publicado: (2018)

An Update on Vitamin D and Disease Activity in Multiple Sclerosis
por: Smolders, Joost, et al.
Publicado: (2019)

The Brain Proteome of the Ubiquitin Ligase Peli1 Knock-Out Mouse during Experimental Autoimmune Encephalomyelitis
por: Lereim, Ragnhild Reehorst, et al.
Publicado: (2016)

The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis
por: Lie, Ingrid Anne, et al.
Publicado: (2022)

Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies
por: Kleinmanns, Katrin, et al.
Publicado: (2022)

Molecular and phenotypic characteristics influencing the degree of cytoreduction in high‐grade serous ovarian carcinomas
por: Torkildsen, Cecilie Fredvik, et al.
Publicado: (2023)

Neurofilament light chain predicts disease activity in relapsing-remitting MS
por: Varhaug, Kristin N., et al.
Publicado: (2017)

Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis
por: Norborg, Hilde, et al.
Publicado: (2021)

Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry
por: Hallin, Erik I., et al.
Publicado: (2022)

Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis – Association and Prediction
por: Løken-Amsrud, Kristin I., et al.
Publicado: (2013)

No association of tobacco use and disease activity in multiple sclerosis
por: Kvistad, Silje, et al.
Publicado: (2016)

High incidence and prevalence of MS in Møre and Romsdal County, Norway, 1950–2018
por: Willumsen, Johannes Sverre, et al.
Publicado: (2020)

Epstein-Barr Virus in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Multiple Sclerosis—Association and Causation
por: Lossius, Andreas, et al.
Publicado: (2012)

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
por: Varhaug, Kristin N., et al.
Publicado: (2019)

Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity
por: Holmøy, Trygve, et al.
Publicado: (2013)

Mortality and cause of death in multiple sclerosis in western Norway 1950–2021: a registry-based linkage study
por: Willumsen, Johannes Sverre, et al.
Publicado: (2022)

Primary Treatment Effects for High-Grade Serous Ovarian Carcinoma Evaluated by Changes in Serum Metabolites and Lipoproteins
por: Torkildsen, Cecilie Fredvik, et al.
Publicado: (2023)

Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study
por: Lie, Ingrid Anne, et al.
Publicado: (2022)

Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study
por: Bjørnevik, Kjetil, et al.
Publicado: (2016)

Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study
por: Cortese, Marianna, et al.
Publicado: (2015)

Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study
por: Bjørnevik, Kjetil, et al.
Publicado: (2016)

Serum markers of multiple sclerosis - a new approach
por: Torkildsen, Øivind
Publicado: (2021)

Patient‐reported outcome after treatment for definite Lyme neuroborreliosis
por: Eikeland, Randi, et al.
Publicado: (2020)

Microstructural changes precede depression in patients with relapsing-remitting Multiple Sclerosis
por: Riemer, Frank, et al.
Publicado: (2023)

Elective induction of labor: A prospective observational study
por: Dögl, Malin, et al.
Publicado: (2018)

Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades
por: Grytten, N, et al.
Publicado: (2015)

Disease-modifying treatments for multiple sclerosis – a review of approved medications
por: Torkildsen, Ø, et al.
Publicado: (2016)

Six versus 2 weeks treatment with doxycycline in European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blinded, randomised and placebo-controlled trial
por: Solheim, Anne Marit, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_51q39ki2h3arbal0ujgjgs7drb